frenolicin b has been researched along with fr 148083 in 1 studies
| Studies (frenolicin b) | Trials (frenolicin b) | Recent Studies (post-2010) (frenolicin b) | Studies (fr 148083) | Trials (fr 148083) | Recent Studies (post-2010) (fr 148083) |
|---|---|---|---|---|---|
| 18 | 0 | 9 | 23 | 0 | 21 |
| Protein | Taxonomy | frenolicin b (IC50) | fr 148083 (IC50) |
|---|---|---|---|
| Dual specificity mitogen-activated protein kinase kinase 7 | Homo sapiens (human) | 0.8 | |
| Mitogen-activated protein kinase kinase kinase 7 | Homo sapiens (human) | 0.017 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 2.5393 | |
| Nuclear receptor subfamily 2 group C member 2 | Homo sapiens (human) | 0.009 | |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | 0.0296 | |
| Transcription factor p65 | Homo sapiens (human) | 0.25 | |
| TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 | Homo sapiens (human) | 0.0087 | |
| Phospholipase A-2-activating protein | Homo sapiens (human) | 0.011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barf, T; Kaptein, A | 1 |
1 review(s) available for frenolicin b and fr 148083
| Article | Year |
|---|---|
Irreversible protein kinase inhibitors: balancing the benefits and risks.
Topics: Animals; Cell Line; Humans; Protein Kinase Inhibitors; Protein Kinases; Risk; Structure-Activity Relationship; Time Factors | 2012 |